The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group
Open accessAbstract
A Task Force was established by the International Restless Legs Syndrome Study Group (IRLSSG) to develop evidence-based and consensus-based recommendations for the long-term pharmacologic treatment of restless legs syndrome/Willis-Ekbom disease (RLS/WED). The Task Force reviewed the results of all studies of RLS/WED treatments with durations of 6 months or longer presented at meetings over the past 2 years, posted on Web sites of pharmaceutical companies, or published in peer-reviewed journals, asking the questions, "What is the efficacy of this treatment in patients with RLS/WED?" and "What is the safety of this treatment in patients with RLS/WED?" The Task Force developed guidelines based on their review of 61 papers meeting inclusion criteria, and using a modified evidence-grading scheme. Pregabalin has been established as effective for up to 1 year in treating RLS/WED (Level A evidence). Pramipexole, ropinirole, and rotigotine have been established as effective for up to 6 months in treating RLS/WED (Level A). The following drugs have been established as probably effective (Level B) in treating RLS/WED for durations ranging from 1 to 5 years: gabapentin enacarbil, pramipexole, and ropinirole (1 year); levodopa (2 years); and rotigotine (5 years). Because of associated safety concerns, pergolide and cabergoline should not be used in the treatment of RLS/WED unless the benefits clearly outweigh the risks. Other pharmacologic therapies have insufficient evidence to support their long-term use in treating RLS/WED. The IRLSSG Task Force also developed consensus-based strategies for the prevention and treatment of complications (such as augmentation, loss of efficacy, excessive daytime sleepiness, and impulse control disorders) that may develop with the long-term pharmacologic treatment of RLS/WED. The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Self-citationSystems to rate the strength of scientific evidence.
West, S. L., King, V., Carey, T. S., Lohr, K. N., Mckoy, N. A., Sutton, S. F., & Lux, L. J. (2002) · PubMed · Cited by 923
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Brainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
An American Academy of Sleep Medicine Review
Sateia, M. J., Doghramji, K., Hauri, P., & Morin, C. M. (2000) · Cited by 370
The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
(1999) · Sleep · doi:10.1093/sleep/22.7.970 · Cited by 322
A questionnaire study of 138 patients with restless legs syndrome: The `Night-Walkers' survey
Walters, A. S., Hickey, K., Maltzman, J., Verrico, T., Joseph, D., Hening, W., Wilson, V., & Chokroverty, S. (1996) · Neurology · doi:10.1212/wnl.46.1.92 · Cited by 319
An Algorithm for the Management of Restless Legs Syndrome
Silber, M. H., Ehrenberg, B. L., Allen, R. P., Buchfuhrer, M. J., Earley, C. J., Hening, W. A., & Rye, D. B. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.7.916 · Cited by 300
Self-citationSchenck, C. H., & Mahowald, M. W. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89493-4 · Cited by 291
Practice Parameters for the Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
Chesson, A. L., Wise, M., Davila, D., Johnson, S., Littner, M., Anderson, W. M., Hartse, K., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.7.961 · Cited by 287
García-Borreguero, D., Allen, R. P., Kohnen, R., Högl, B., Trenkwalder, C., Oertel, W., Hening, W. A., Paulus, W., Rye, D., Walters, A., et al. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.022 · Cited by 285
Self-citationLeone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 280
Hening, W. A., Allen, R. P., Earley, C. J., Picchietti, D. L., & Silber, M. H. (2004) · Sleep · doi:10.1093/sleep/27.3.560 · Cited by 272
Self-citationTreatment of restless legs syndrome: An evidence‐based review and implications for clinical practice
Trenkwalder, C., Hening, W. A., Montagna, P., Oertel, W. H., Allen, R. P., Walters, A. S., Costa, J., Stiasny‐Kolster, K., & Sampaio, C. (2008) · Movement Disorders · doi:10.1002/mds.22254 · Cited by 264
Self-citationTreatment of Restless Legs Syndrome With Levodopa Plus Benserazide
Akpinar, S. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510230065027 · Cited by 230
Valvular Heart Disease in Patients Taking Pergolide
Pritchett, A. M., Morrison, J. F., Edwards, W. D., Schaff, H. V., Connolly, H. M., & Espinosa, R. E. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.12.1280 · Cited by 222
Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
Winkelman, J. W., & Johnston, L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2003.07.005 · Cited by 217
Self-citationLong‐Term follow‐up on restless legs syndrome patients treated with opioids
Walters, A. S., Winkelmann, J., Trenkwalder, C., Fry, J. M., Kataria, V., Wagner, M., Sharma, R., Hening, W., & Li, L. (2001) · Movement Disorders · doi:10.1002/mds.1214 · Cited by 210
Wang, J., O’Reilly, B., Venkataraman, R., Mysliwiec, V., & Mysliwiec, A. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.11.003 · Cited by 209
Trenkwalder, C., Beneš, H., Poewe, W., Oertel, W. H., Garcia-Borreguero, D., de Weerd, A. W., Ferini-Strambi, L., Montagna, P., Odin, P., Stiasny-Kolster, K., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70112-1 · Cited by 202
Self-citationSilver, N., Allen, R. P., Senerth, J., & Earley, C. J. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.11.002 · Cited by 197
Self-citationRestless legs syndrome: Understanding its consequences and the need for better treatment
Earley, C. J., & Silber, M. H. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.07.007 · Cited by 196
Self-citationEarley, C. J., & Allen, R. P. (1996) · Sleep · doi:10.1093/sleep/19.10.801 · Cited by 182
Self-citationMethadone for refractory restless legs syndrome
Ondo, W. G. (2004) · Movement Disorders · doi:10.1002/mds.20359 · Cited by 157
Littner, M. R., Kushida, C. A., Anderson, W. M., Bailey, D. R., Berry, R. B., Hirshkowitz, M., Kapen, S., KRAMER, M. L., Lee-Chiong, T. L., Li, K. K., et al. (2004) · SLEEP · doi:10.1093/sleep/27.3.557 · Cited by 150
Garcı́a-Borreguero, D., Ferini‐Strambi, L., Kohnen, R., O’Keeffe, S. T., Trenkwalder, C., Högl, B., Beneš, H., Jennum, P., Partinen, M., Fer, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03853.x · Cited by 150
Self-citationAllen, R. P., Adler, C. H., Du, W., Butcher, A., Bregman, D. B., & Earley, C. J. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.06.009 · Cited by 148
Self-citationOertel, W. H., Trenkwalder, C., Beneš, H., Ferini‐Strambi, L., Högl, B., Poewe, W. H., Stiasny‐Kolster, K., Fichtner, A., Schollmayer, E., Kohnen, R., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70127-2 · Cited by 146
Self-citationEFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep
Vignatelli, L., Billiard, M., Clarenbach, P., Garcia‐Borreguero, D., Kaynak, D., Liesiene, V., Trenkwalder, C., & Montagna, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01410.x · Cited by 144
Self-citationPramipexole in the Management of Restless Legs Syndrome: An Extended Study
Silber, M. H., Girish, M., & Izurieta, R. (2003) · SLEEP · doi:10.1093/sleep/26.7.819 · Cited by 142
Self-citationEarley, C. J., Horská, A., Mohamed, M. A., Barker, P. B., Beard, J. L., & Allen, R. P. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.12.006 · Cited by 135
Self-citationAssessing health-related quality of life in patients with restless legs syndrome
Happe, S., Reese, J. P., Stiasny‐Kolster, K., Peglau, I., Mayer, G., Klotsche, J., Giani, G., Geraedts, M., Trenkwalder, C., & Dodel, R. C. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2008.01.002 · Cited by 134
Grote, L., Leissner, L. C., Hedner, J. A., & Ulfberg, J. (2009) · Movement Disorders · doi:10.1002/mds.22562 · Cited by 131
Pramipexole in the treatment of restless legs syndrome: a follow‐up study
Montplaisir, J. Y., Denesle, R., & Petit, D. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.0070s1027.x · Cited by 127
Self-citationTreatment of Restless Legs Syndrome with Gabapentin
Adler, C. H. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199704000-00006 · Cited by 117
Dopamine agonists and cardiac valvulopathy in Parkinson disease: A case–control study
Yamamoto, M., Uesugi, T., & Nakayama, T. (2006) · Neurology · doi:10.1212/01.wnl.0000238508.68593.1d · Cited by 113
Long-term use of pramipexole in the management of restless legs syndrome
Lipford, M. C., & Silber, M. H. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.08.004 · Cited by 113
Self-citationHening, W. A., Allen, R. P., Ondo, W. G., Walters, A. S., Winkelman, J. W., Becker, P. M., Bogan, R., Fry, J. M., Kudrow, D., Lesh, K. W., et al. (2010) · Movement Disorders · doi:10.1002/mds.23157 · Cited by 112
Self-citationHögl, B., Garcı́a-Borreguero, D., Kohnen, R., Ferini‐Strambi, L., Hadjigeorgiou, G. M., Hornyak, M., de Weerd, A., Happe, S., Stiasny‐Kolster, K., Gschliesser, V., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5299-8 · Cited by 107
Self-citationTrenkwalder, C., Beneš, H., Grote, L., Happe, S., Högl, B., Mathis, J., Saletu-Zyhlarz, G. M., Kohnen, R., & CALDIR study group (2007) · Movement Disorders · doi:10.1002/mds.21401 · Cited by 106
Self-citationTreatment of Restless Legs Syndrome With Tramadol: An Open Study
Lauerma, H., & Markkula, J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0407 · Cited by 102
Montplaisir, J. Y., Karrasch, J., Haan, J., & Volc, D. (2006) · Movement Disorders · doi:10.1002/mds.21050 · Cited by 97
Self-citationLong-term Treatment of Restless Legs Syndrome With Dopamine Agonists
Ondo, W. G., Romanyshyn, J. C., Vuong, K. D., & Lai, D. (2004) · Archives of Neurology · doi:10.1001/archneur.61.9.1393 · Cited by 94
Restless legs syndrome augmentation associated with tramadol
Earley, C. J., & Allen, R. P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.05.011 · Cited by 91
Self-citationEfficacy and augmentation during 6months of double-blind pramipexole for restless legs syndrome
Högl, B., Garcı́a-Borreguero, D., Trenkwalder, C., Ferini‐Strambi, L., Hening, W. A., Poewe, W. H., Brenner, S. S., Fraessdorf, M., Busse, M., Albrecht, S., et al. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.12.007 · Cited by 87
Self-citationTrenkwalder, C., Stiasny‐Kolster, K., Kupsch, A. R., Oertel, W. H., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.20983 · Cited by 85
Management of Restless Legs Syndrome With Gabapentin (Neurontin®)
Mellick, G. A., & Mellick, L. B. (1996) · SLEEP · doi:10.1093/sleep/19.3.224 · Cited by 82
Garcı́a-Borreguero, D., Högl, B., Ferini‐Strambi, L., Winkelman, J. W., Hill‐Zabala, C. E., Asgharian, A., & Allen, R. P. (2012) · Movement Disorders · doi:10.1002/mds.24889 · Cited by 78
Self-citationBogan, R., Bornemann, M. A. C., Kushida, C. A., Trân, P. V., & Barrett, R. W. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0700 · Cited by 73
García-Borreguero, D., Grunstein, R. R., Sridhar, G., Dreykluft, T., Montagna, P., Dom, R., Lainey, E., Moorat, A., & Roberts, J. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.09.009 · Cited by 72
Pregabalin in restless legs syndrome with and without neuropathic pain
Sommer, M., Bachmann, C. G., Liebetanz, K. M., Schindehütte, J., Tings, T., & Paulus, W. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00796.x · Cited by 69
Trenkwalder, C., Collado-Seidel, V., Kazenwadel, J., Wetter, T. C., Oertel, W. H., Selzer, R., & Kohnen, R. (2003) · Movement Disorders · doi:10.1002/mds.10503 · Cited by 67
Self-citationTask Force 1: Training in Clinical Cardiology
Baughman, K. L., Duffy, F. D., Eagle, K. A., Faxon, D. P., Hillis, L. D., & Lange, R. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.009 · Cited by 67
McCrink, L., Allen, R. P., Wolowacz, S. E., Sherrill, B. H., Connolly, M. P., & Kirsch, J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.03.014 · Cited by 54
Self-citationLong‐term treatment with pramipexole in restless legs syndrome
Montplaisir, J. Y., Fantini, M. L., Désautels, A., Michaud, M., Petit, D., & Filipini, D. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01459.x · Cited by 51
Self-citationA 52-Week Study of Gabapentin Enacarbil in Restless Legs Syndrome
Ellenbogen, A. L., Thein, S., Winslow, D. H., Becker, P. M., Tolson, J. M., Lassauzet, M.-L., & Chen, D. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182087d48 · Cited by 48
Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery
Jakobsson, B., & Ruuth, K. (2002) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2002.460121.x · Cited by 45
Partinen, M., Hirvonen, K., Jama, L., Alakuijala, A., Hublin, C., Tamminen, I., Koester, J., & Reess, J. (2008) · Sleep Medicine · doi:10.1016/j.sleep.2007.12.004 · Cited by 36
Long-term open-label study of pramipexole in patients with primary restless legs syndrome
Inoue, Y., Kuroda, K., Hirata, K., Uchimura, N., Kagimura, T., & Shimizu, T. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.04.003 · Cited by 35
Self-citationLong-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients
Inoue, Y., Uchimura, N., Kuroda, K., Hirata, K., & Hattori, N. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.10.009 · Cited by 33
Self-citationPiribedil for restless legs syndrome: A pilot study
Evidente, V. G. H. (2001) · Movement Disorders · doi:10.1002/mds.1104 · Cited by 32
García-Borreguero, D., Allen, R. P., Kohnen, R., Beneš, H., Winkelman, J. W., Högl, B., Ferini‐Strambi, L., Zucconi, M., & Trenkwalder, C. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.001 · Cited by 23
Self-citationRopinirole and restless legs syndrome
G�lvez-Jim�nez, N., & Khan, T. (1999) · Movement Disorders · Cited by 21
Lebensqualität beim Restless-Legs-Syndrom
Gerhard, R., Bosse, A., Uzun, D., Orth, M., & Kotterba, S. (2005) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-005-1097-y · Cited by 17
Pergolide Associated Cardiac Valvulopathy Based on Ontario Administrative Data
Zadikoff, C., Duong-Hua, M., Sykora, K., Marras, C., Lang, A. E., & Rochon, P. A. (2008) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100008593 · Cited by 12
Quality of Life in Restless Legs Syndrome
Speight, J., & Howarth, A. (2010) · Patient · doi:10.2165/11534390-000000000-00000 · Cited by 6
Cited by
Allen, R. P., Picchietti, D. L., Garcia-Borreguero, D., Ondo, W. G., Walters, A. S., Winkelman, J. W., Zucconi, M., Ferri, R., Trenkwalder, C., & Lee, H. B. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.03.025 · Cited by 1,609
Self-citationZamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009654 · Cited by 1,103
Allen, R. P., Picchietti, D. L., Auerbach, M., Cho, Y. W., Connor, J. R., Earley, C. J., Garcia-Borreguero, D., Kotagal, S., Manconi, M., Ondo, W., et al. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2017.11.1126 · Cited by 349
Self-citationGarcia-Borreguero, D., Silber, M. H., Winkelman, J. W., Högl, B., Bainbridge, J., Buchfuhrer, M., Hadjigeorgiou, G., Inoue, Y., Manconi, M., Oertel, W., et al. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.01.017 · Cited by 342
Self-citationManconi, M., Garcia-Borreguero, D., Schormair, B., Videnovic, A., Berger, K., Ferri, R., & Dauvilliers, Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00311-z · Cited by 271
Self-citation
Metadata
- Authors
- Garcia-Borreguero, D., Kohnen, R., Silber, M. H., Winkelman, J. W., Earley, C. J., Högl, B., Manconi, M., Montplaisir, J., Inoue, Y., & Allen, R. P.
- Venue
- Sleep Medicine
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 14
- Issue
- 7
- Pages
- 675-684
- ISSN
- 1389-9457 (ISSN-L)
- OpenAlex
- W2139927499
- Cited by
- 291
- References
- 67
- FWCI
- 27.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.